Granulopoiesis‐stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

BACKGROUND: Granulopoiesis‐stimulating factors, such as granulocyte‐colony‐stimulating factor (G‐CSF) and granulocyte‐macrophage‐colony‐stimulating factor (GM‐CSF), are being used to prevent febrile neutropenia and infection in patients undergoing treatment for malignant lymphoma. The question of wh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Bohlius, Julia, Herbst, Christine, Reiser, Marcel, Schwarzer, Guido, Engert, Andreas
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2008
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7144686/
https://ncbi.nlm.nih.gov/pubmed/18843642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003189.pub4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars